Thibaut Mongon - 10 Feb 2023 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role: Exec VP, WW Chair, Cons Health
Signature: Raavi K. Deol, as attorney-in-fact for Thibaut Mongon
Issuer symbol: JNJ
Transactions as of: 10 Feb 2023
Net transactions value: -$133,878
Form type: 4
Filing time: 14 Feb 2023, 15:35:37 UTC
Previous filing: 09 Nov 2022
Next filing: 15 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JNJ	Common Stock	Options Exercise	$0	+2,285	+4%	$0.000000	59,461	10 Feb 2023	Direct	F1
transaction	JNJ	Common Stock	Tax liability	$133,878	-826	-1.4%	$162.08	58,635	10 Feb 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JNJ	Restricted Share Units	Options Exercise	$0	-2,285	-100%	$0.000000^*	0	10 Feb 2023	Common Stock	2,285		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.
F2	Shares withheld for payment of taxes upon vesting of Restricted Share Units.